Clinical trial
Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania…
NCT00448578 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00448578 |
|---|---|
| Title | Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients |
| Official title | A Double Dummy & Double Blind, Multicenter, Randomized Study of the Efficacy and Safety of Seroquel (Quetiapine Fumarate) and Lithium as Monotherapy in the Treatment of Acute Mania in Patients With Bipolar Disorder |
| Acronym | STAR |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mania, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine Fumarate, Lithium |
| Enrollment | 150 |
| Start date | Aug 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Mar 19, 2007 |
| Last update posted | Dec 9, 2010 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: